ArticleBlood2017
Recombinant ADAMTS-13: first-in-human pharmacokinetics and safety in congenital thrombotic thrombocytopenic purpura.
Marie Scully et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
108 papers cite itlatest 60 shown
this papertrialcites it